查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1750775

口服固体製剂契约製造市场规模、份额、趋势分析报告：按产品、机制、最终用途、地区、细分市场预测，2025-2030 年

Oral Solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report By Product (Tablets, Capsules, Powders, Granules), By Mechanism (Controlled Release, Immediate Release), By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 178 Pages | 商品交期: 2-10个工作天内

价格

口服固体製剂契约製造市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，全球口服固体製剂契约製造市场规模预计到2030年将达到547.2亿美元，2025年至2030年的复合年增长率为5.99%。

新药分子日益复杂、大型 CMO 和 CDMO 的研发投资以及对新疗法的需求不断增长是推动市场成长的主要因素。

口服固体製剂因其成本效益高、易于生产且患者友善等特点，在製药业广受欢迎。此外，控制释放和缓释製剂等药物传递技术的进步，使得口服固体製剂能达到更高的生物有效性度，同时降低给药频率。这有望推动市场成长潜力。

口服固体製剂开发和大量生产技术的进步是此类产品快速商业化的主要因素之一。目前，市面上有各种各样的剂型。然而，营养保健品和製药业始终专注于口服固体製剂（OSD）剂型的开发，因为其易于操作、服用方便且患者依从性良好。 OSD製剂技术和材料的蓬勃发展预计将推动对此类製剂的需求。

此外，CMO/CDMO的研发投入正在促进生产流程、製剂开发和分析技术的创新。这有助于在口服固体製剂的生产中采用更有效率、更先进的生产技术。研发投入还能提高生产能力和可扩充性，使CMO/CDMO能够提供更多口服固体製剂，以满足製药公司日益增长的需求。

此外，该产业在 2023 年出现了许多策略性倡议，包括联盟、伙伴关係、併购和服务扩展。

  • 2023年7月，Aenova集团与Galvita建立策略伙伴关係，以改善口服药物的配方、生产和开发。
  • 2023 年 4 月，Aenova 投资约 2,196 万美元（2,000 万欧元）扩建其位于蒂特莫宁的散装固态剂量生产基地，以提高生产能力。
  • 2023 年 1 月，Catalent 和 Ethicann 合作，利用 Catalent 的口溶锭(ODT) 技术开发 Ethicann 的临床药物管线。

口服固体製剂契约製造市场报告重点

  • 2024年，锭剂市场占据主导地位，收入份额达32.74%。锭剂因其成本效益高、结构紧凑、易于生产和方便自行服用等特点，成为最常见且最受欢迎的口服缓释片 (OSD) 剂型。双层片剂需求的不断增长，以及企业在扩大製剂配方和控制释放锭剂生产方面的投资，预计将推动市场成长。
  • 控制释放锭剂市场在2024年占据了最大的份额。这一增长可归因于口服控制释放给药系统（例如圆顶片、双剂量锭剂、肠道贴片、聚合物奈米系统）以及仿生给药方法（例如用于精准药物递送的外泌体）的进步。因此，对控制释放剂型的旺盛需求预计将在不久的将来推动该市场的收益成长。
  • 从最终用途来看，大型企业在2024年占据了最大的份额。固态剂型製造市场日益以协作、灵活性和高适应性为特征。越来越多的製药开发公司打算从零开始设计药物，并将其委託给领先的CMO，从而加速市场成长。此外，专门从事口服固体製剂的CMO正受到越来越多的青睐，因为它们可以为大型製药企业带来许多益处。
  • 预计亚太地区将在2024年引领全球市场，并在预测期内实现最快的复合年增长率。中国和印度是口服固体製剂契约製造的强国，且价格明显较低。此外，新加坡、印度和韩国等亚洲国家由于生产能力不断提升，被视为製药业的主要参与者。

目录

第一章调查方法与范围

第二章执行摘要

第三章市场变数、趋势和范围

  • 市场展望
    • 母市场展望
    • 相关/支持市场展望
  • 市场趋势与展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 技术格局
    • 製造技术
    • 封装技术
    • 涂层技术
    • 包装技术
    • 分析技术
  • 定价模式分析
  • 产业分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19影响分析

第四章口服固体製剂契约製造市场：产品评估与趋势分析

  • 细分仪表板
  • 口服固体製剂契约製造市场：产品差异分析
  • 口服固体製剂契约製造市场规模及趋势分析（依产品，2018-2030 年）
  • 药片
  • 胶囊
  • 粉末
  • 颗粒
  • 其他的

第五章口服固体製剂契约製造市场：机制评估与趋势分析

  • 细分仪表板
  • 口服固体製剂契约製造市场：机制波动分析
  • 口服固体製剂契约製造规模及趋势分析（依机制，2018-2030）
  • 即时释放
    • 延迟释放
    • 控释

第六章口服固体製剂契约製造市场：最终用途估计与趋势分析

  • 细分仪表板
  • 口服固体製剂契约製造市场：最终用途差异分析
  • 2018-2030年口服固体製剂契约製造规模及趋势分析（依最终用途）
  • 大公司
  • 中小企业
  • 其他的

第七章口服固体製剂契约製造市场：按地区分類的业务分析

  • 区域仪表板
  • 2018-2030年市场规模、预测与趋势分析
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲

第八章 竞争态势

  • 公司分类
  • 2024年企业市场分析
  • 公司简介
    • Catalent, Inc.
    • Lonza
    • Aenova Group
    • Boehringer Ingelheim International GmbH
    • Jubilant Pharmova Limited
    • Patheon Pharma Services
    • Recipharm AB.
    • Corden Pharma International
    • Siegfried Holding AG
    • Piramal Pharma Solutions
    • AbbVie Contract Manufacturing
    • Next Pharma AB
Product Code: GVR-4-68039-948-4

Oral Solid Dosage Contract Manufacturing Market Growth & Trends:

The global oral solid dosage contract manufacturing market size is estimated to reach USD 54.72 billion by 2030, registering a CAGR of 5.99% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing complexity of new drug molecules, R&D investments by large CMOs & CDMOs and rising demand for novel therapies are key factors driving market growth.

Oral solids are widely accepted dosage forms in the pharmaceutical sector since they are cost-effective, simple to manufacture, and patient-friendly. Furthermore, advances in drug delivery technology, such as control release and sustained release formation, are enabling oral solids to achieve even higher levels of bioavailability while lowering drug administration frequency. Thereby, it is anticipated to propel market growth potential.

Technological advancements in the development and bulk manufacturing of oral solid dosage forms are among the primary factors supporting the fast-track commercialization of these products. Currently, a diverse array of dosage forms is accessible in the market. However, the nutraceutical and pharmaceutical industries consistently put effort into developing OSD forms. This preference is due to their ease of handling, convenient consumption, and positive patient adherence. Anticipated advancements in technology and materials of OSD forms are projected to boost the demand for these formulations.

Furthermore, R&D investments by CMOs and CDMOs contribute to enhanced innovation in manufacturing processes, formulation development, & analytical technologies. This can lead to the adoption of more efficient and advanced manufacturing techniques in the production of oral solid dosage forms. Also, investments in R&D result in the expansion of manufacturing capabilities and improved scalability. This allows CMOs and CDMOs to offer larger volumes of oral solid dosage production to meet the increasing demand from pharmaceutical companies.

Moreover, the industry witnessed many strategic movements in 2023, such as collaborations, partnerships, M&As, service expansion, etc.

  • In July 2023, Aenova Group and Galvita entered a strategic partnership to improve the formulation, production, and development of oral dosage forms.
  • In April 2023, Aenova invested approximately USD 21.96 million (20 million euros) to expand its high-volume solids site in Tittmoning, resulting in increased capacity.
  • In January 2023, Catalent and Ethicann collaborated to develop Ethicann's clinical drug pipeline using Catalent's technology known as Orally Disintegrating Tablet (ODT) technology.

Oral Solid Dosage Contract Manufacturing Market Report Highlights:

  • The tablets segment dominated the market with a revenue share of 32.74% in 2024. Tablets are the most common and preferred OSD form due to their cost-effectiveness, high compactness, easy manufacturing, and convenience of self-administration. Increased demand for bilayer tablets and investments by firms to expand formulation and controlled-release tablet manufacturing are predicted to drive market growth.
  • The controlled release segment accounted for the largest share in 2024. This growth is attributed to advancements in oral controlled release delivery systems, including dome tablets, dual drug tablets, intestinal patches, polymer nanosystems, and bioinspired delivery methods, such as exosomes for precise drug delivery. Thus, high demand for control release dosage forms is anticipated to boost segmental revenue growth in the near future.
  • Based on end-use, the large size companies segment accounted for the largest share in 2024. The solid dose manufacturing market is increasingly defined by collaboration, flexibility, and high adaptability. More pharma developers design drugs from the start, intending to outsource them to large CMOs, thereby accelerating market growth. Furthermore, CMOs specializing in oral solid dosage can provide several benefits to large pharmaceutical companies, leading to their increased adoption.
  • Asia Pacific led the global market in 2024 and is projected to witness the fastest CAGR over the forecast period. China and India are the powerhouses of oral solid dosage contract manufacturing organizations with significantly lower prices. Further, expanding manufacturing capabilities among Asian countries such as Singapore, India, and South Korea have been considered major players in the pharmaceutical industry due to their expanding manufacturing capabilities.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Regional Scope
    • 1.1.2. Estimates and Forecast Timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Purchased Database
    • 1.3.3. GVR's Internal Database
    • 1.3.4. Secondary Sources
    • 1.3.5. Primary Research
  • 1.4. Information or Data Analysis
    • 1.4.1. Information Analysis
    • 1.4.2. Market Formulation & Data Visualization
    • 1.4.3. Data Validation & Publishing
  • 1.5. Model Details
    • 1.5.1. Commodity Flow Analysis (Model 1)
    • 1.5.2. Top Down Market Estimation (Model 2)
    • 1.5.3. Value-Chain-Based Sizing & Forecasting (Model 3)
    • 1.5.4. Multivariate Analysis (Model 4)
  • 1.6. List of Secondary Sources
  • 1.7. List of Abbreviations
  • 1.8. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
      • 3.3.1.1. Technological Advancements in Oral Solid Dosage (OSD) Forms
      • 3.3.1.2. Expansion of Manufacturing Capacity by CMOs & CDMOs for OSD
      • 3.3.1.3. Increasing Demand for Novel Therapies
      • 3.3.1.4. Increasing Demand for One-Stop-Shop CMOs
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. Strict Approval Criteria by Regulatory Authorities
      • 3.3.2.2. Lack of Experienced Technical Staff, Physical Capability, and Equipment Capacity
      • 3.3.2.3. Increasing Need for Biosimilars and Their Prominence in Addressing Cancer & Other Medical Conditions
  • 3.4. Technology Landscape
    • 3.4.1. Manufacturing Technology
    • 3.4.2. Encapsulation Technology
    • 3.4.3. Coating Technology
    • 3.4.4. Packaging Technology
    • 3.4.5. Analytical Technology
  • 3.5. Pricing Model Analysis
  • 3.6. Industry Analysis Tools
    • 3.6.1. Porter's Five Forces Analysis
    • 3.6.2. PESTEL Analysis
    • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Oral Solid Dosage Contract Manufacturing Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Oral Solid Dosage Contract Manufacturing Market; Product Movement Analysis
  • 4.3. Oral Solid Dosage Contract Manufacturing Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Tablets
    • 4.4.1. Tablets market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5. Capsules
    • 4.5.1. Capsules market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.6. Powders
    • 4.6.1. Powders market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.7. Granules
    • 4.7.1. Granules market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Oral Solid Dosage Contract Manufacturing Market: Mechanism Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Oral Solid Dosage Contract Manufacturing Market; Mechanism Movement Analysis
  • 5.3. Oral Solid Dosage Contract Manufacturing Size & Trend Analysis, by Mechanism, 2018 to 2030 (USD Million)
  • 5.4. Immediate Release
    • 5.4.1. Immediate release market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. Delayed Release
      • 5.4.2.1. Delayed release market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Controlled Release
      • 5.4.3.1. Controlled release market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Oral Solid Dosage Contract Manufacturing Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Oral Solid Dosage Contract Manufacturing Market; End Use Movement Analysis
  • 6.3. Oral Solid Dosage Contract Manufacturing Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Large Size Companies
    • 6.4.1. Large size companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5. Medium & Small Size Companies
    • 6.5.1. Medium & small size companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Oral Solid Dosage Contract Manufacturing Market: Regional Business Analysis

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 7.3. North America
    • 7.3.1. North America oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Competitive scenario
      • 7.3.2.3. Regulatory framework
      • 7.3.2.4. U.S. oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Competitive scenario
      • 7.3.3.3. Regulatory framework
      • 7.3.3.4. Canada oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key country dynamics
      • 7.3.4.2. Competitive scenario
      • 7.3.4.3. Regulatory framework
      • 7.3.4.4. Mexico oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Competitive scenario
      • 7.4.2.3. Regulatory framework
      • 7.4.2.4. Germany oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. UK
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Competitive scenario
      • 7.4.3.3. Regulatory framework
      • 7.4.3.4. UK oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Competitive scenario
      • 7.4.4.3. Regulatory framework
      • 7.4.4.4. France oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Competitive scenario
      • 7.4.5.3. Regulatory framework
      • 7.4.5.4. Italy oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Competitive scenario
      • 7.4.6.3. Regulatory framework
      • 7.4.6.4. Spain oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Competitive scenario
      • 7.4.7.3. Regulatory framework
      • 7.4.7.4. Denmark oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Competitive scenario
      • 7.4.8.3. Regulatory framework
      • 7.4.8.4. Sweden oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key country dynamics
      • 7.4.9.2. Competitive scenario
      • 7.4.9.3. Regulatory framework
      • 7.4.9.4. Norway oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory framework
      • 7.5.2.4. Japan oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Regulatory framework
      • 7.5.3.4. China oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Competitive scenario
      • 7.5.4.3. Regulatory framework
      • 7.5.4.4. India oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Competitive scenario
      • 7.5.5.3. Regulatory framework
      • 7.5.5.4. South Korea oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Competitive scenario
      • 7.5.6.3. Regulatory framework
      • 7.5.6.4. Australia oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Competitive scenario
      • 7.5.7.3. Regulatory framework
      • 7.5.7.4. Thailand oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Brazil oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory framework
      • 7.6.3.4. Argentina oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. South Africa oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Saudi Arabia oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Competitive scenario
      • 7.7.4.3. Regulatory framework
      • 7.7.4.4. UAE oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Competitive scenario
      • 7.7.5.3. Regulatory framework
      • 7.7.5.4. Kuwait oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Company Market Position Analysis, 2024
  • 8.3. Company Profiles
    • 8.3.1. Catalent, Inc.
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Service benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. Lonza
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Service benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Aenova Group
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Service benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Boehringer Ingelheim International GmbH
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Service benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Jubilant Pharmova Limited
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Service benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Patheon Pharma Services
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Service benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Recipharm AB.
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Service benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Corden Pharma International
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Service benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Siegfried Holding AG
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Service benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Piramal Pharma Solutions
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Service benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. AbbVie Contract Manufacturing
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Service benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Next Pharma AB
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Service benchmarking
      • 8.3.12.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America Oral Solid Dosage Contract Manufacturing Market, by Region, 2018 - 2030 (USD Million)
  • Table 3 North America Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 4 North America Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 5 North America Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 6 U.S. Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 7 U.S. Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 8 U.S. Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 9 Canada Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 10 Canada Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 11 Canada Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 12 Mexico Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 13 Mexico Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 14 Mexico Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 15 Europe Oral Solid Dosage Contract Manufacturing market, by Region, 2018 - 2030 (USD Million)
  • Table 16 Europe Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 17 Europe Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 18 Europe Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 19 UK Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 20 UK Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 21 UK Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 22 Germany Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 23 Germany Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 24 Germany Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 25 France Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 26 France Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 27 France Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 28 Italy Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 29 Italy Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 30 Italy Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 31 Spain Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 32 Spain Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 33 Spain Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 34 Denmark Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 35 Denmark Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 36 Denmark Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 37 Sweden Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 38 Sweden Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 39 Sweden Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 40 Norway Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 41 Norway Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 42 Norway Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Oral Solid Dosage Contract Manufacturing market, by Region, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 47 China Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 48 China Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 49 China Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 50 India Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 51 India Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 52 India Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 53 Japan Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 54 Japan Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 55 Japan Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 56 Australia Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 57 Australia Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 58 Australia Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 59 South Korea Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 60 South Korea Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 61 South Korea Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 62 Thailand Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 63 Thailand Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 64 Thailand Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 65 Latin America Oral Solid Dosage Contract Manufacturing market, by region, 2018 - 2030 (USD Million)
  • Table 66 Latin America Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 67 Latin America Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 68 Latin America Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 69 Brazil Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 70 Brazil Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 71 Brazil Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 72 Argentina Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 73 Argentina Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 74 Argentina Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 75 MEA Oral Solid Dosage Contract Manufacturing market, by Region, 2018 - 2030 (USD Million)
  • Table 76 MEA Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 77 MEA Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 78 MEA Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 79 South Africa Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 80 South Africa Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 81 South Africa Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 85 UAE Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 86 UAE Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 87 UAE Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait Oral Solid Dosage Contract Manufacturing Market, by Product, 2018 - 2030 (USD Million)
  • Table 89 Kuwait Oral Solid Dosage Contract Manufacturing Market, by Mechanism, 2018 - 2030 (USD Million)
  • Table 90 Kuwait Oral Solid Dosage Contract Manufacturing Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Oral solid dosage contract manufacturing market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD model sizing & forecasting
  • Fig. 10 Market formulation & validation
  • Fig. 11 Market snapshot
  • Fig. 12 Segment snapshot
  • Fig. 13 Segment snapshot
  • Fig. 14 Competitive landscape snapshot
  • Fig. 15 Parent market outlook, 2024 (USD Million)
  • Fig. 16 Ancillary market outlook, 2024 (USD Million)
  • Fig. 17 Oral solid dosage contract manufacturing market dynamics
  • Fig. 18 Product approvals in the U.S. and EU per year (2024)
  • Fig. 19 Porter's five forces analysis
  • Fig. 20 PESTEL analysis
  • Fig. 21 Oral solid dosage packaging types in the U.S., 2024 (volume percentage share %)
  • Fig. 22 Oral solid dosage blister packaging types in the U.S., 2024 (volume percentage share %)
  • Fig. 23 Oral solid dosage contract manufacturing market: Product type outlook and key takeaways
  • Fig. 24 Oral solid dosage contract manufacturing market: Product type movement analysis
  • Fig. 25 Tablets oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Capsules oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Powders oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Granules oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Others oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Oral solid dosage contract manufacturing market: Mechanism outlook and key takeaways
  • Fig. 31 Oral solid dosage contract manufacturing market: Mechanism movement analysis
  • Fig. 32 Immediate release contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Delayed release contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Controlled release contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Oral solid dosage contract manufacturing market: End-use outlook and key takeaways
  • Fig. 36 Oral solid dosage contract manufacturing market: End-use movement analysis
  • Fig. 37 Large size companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Medium & small size companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Regional market: Key takeaways
  • Fig. 41 Regional outlook, 2024 & 2030
  • Fig. 42 Regional outlook, 2024 & 2030
  • Fig. 43 North America market, 2018 - 2030 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 U.S. oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Canada oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Europe oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 UK oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Germany oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 France oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Italy oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Spain oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Denmark oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Sweden oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Norway oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Asia Pacific oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 China oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Regulatory bodies in India involved in pharmaceutical regulations
  • Fig. 70 India oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Clinical trial authorization process in Japan
  • Fig. 73 Clinical Research of Medical Products in Japan
  • Fig. 74 Japan oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 78 Australia oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Clinical trial approval process in South Korea
  • Fig. 81 South Korea oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Thailand oral solid dosage contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Latin America Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Brazil Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 Mexico Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Argentina Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 MEA Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 South Africa Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 Saudi Arabia Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 Clinical trial authorization process UAE
  • Fig. 98 UAE Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 Kuwait Oral Solid Dosage Contract Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)